Diagnosis and Treatment Pathway – Asthma
[vc_row][vc_column][vc_custom_heading text="Diagnosis and Treatment Pathway - Asthma" font_container="tag:h2|text_align:center" use_theme_fonts="yes"][/vc_column][/vc_row][vc_row][vc_column css=".vc_c ...
FDA Approves TEZSPIRE® for Self-Administration in Severe Asthma Patients Aged 12+
Amgen and AstraZeneca announced today that TEZSPIRE® (tezepelumab-ekko) has received approval from the U.S. FDA for self-administration in a pre-filled, single-use pen for severe asthma patients aged ...